Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 17479951)

1.

Dysregulated energy expenditure in HIV-infected patients: a mechanistic review.

Chang E, Sekhar R, Patel S, Balasubramanyam A.

Clin Infect Dis. 2007 Jun 1;44(11):1509-17. Epub 2007 Apr 18. Review.

2.

Hyperphagia contributes to the normal body composition and protein-energy balance in HIV-infected asymptomatic men.

Crenn P, Rakotoanbinina B, Raynaud JJ, Thuillier F, Messing B, Melchior JC.

J Nutr. 2004 Sep;134(9):2301-6.

3.

Management trends. Resting energy expenditure in the HAART era.

Shevitz AH.

AIDS Read. 2000 Sep;10(9):539-44; quiz 557-8. Review.

PMID:
11019449
4.

Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.

Roubenoff R, Grinspoon S, Skolnik PR, Tchetgen E, Abad L, Spiegelman D, Knox T, Gorbach S.

Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E138-45.

5.

Energy expenditure and protein metabolism in human immunodeficiency virus infection and cancer cachexia.

Mulligan K, Bloch AS.

Semin Oncol. 1998 Apr;25(2 Suppl 6):82-91. Review.

PMID:
9625389
6.

Protease inhibitor therapy improves protein catabolism in prepubertal children with HIV infection.

Hardin DS, Ellis KJ, Rice J, Doyle ME.

J Pediatr Endocrinol Metab. 2004 Mar;17(3):321-5.

PMID:
15112908
7.

Energy expenditure and wasting in human immunodeficiency virus infection.

Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ, Griffin GE.

N Engl J Med. 1995 Jul 13;333(2):83-8.

8.

Determinants of energy intake and energy expenditure in HIV and AIDS.

Sheehan LA, Macallan DC.

Nutrition. 2000 Feb;16(2):101-6.

PMID:
10696632
9.
10.

Nutrition in the era of highly active antiretroviral therapy.

Shevitz AH, Knox TA.

Clin Infect Dis. 2001 Jun 15;32(12):1769-75. Epub 2001 May 16. Review. Erratum in: Clin Infect Dis 2001 Oct 15;33(8):1445.

11.

Pathogenesis and consequences of HIV-associated wasting.

Wanke C.

J Acquir Immune Defic Syndr. 2004 Dec 1;37 Suppl 5:S277-9.

PMID:
15722870
12.

Metabolic aspects of HIV: associated wasting.

Melchior JC.

Biomed Pharmacother. 1997;51(10):455-60. Review.

PMID:
9863505
13.

Metabolic syndrome associated with HIV and highly active antiretroviral therapy.

Barbaro G, Iacobellis G.

Curr Diab Rep. 2009 Feb;9(1):37-42. Review.

PMID:
19192423
15.

Body composition and nutritional parameters in HIV and AIDS patients.

Salomon J, de Truchis P, Melchior JC.

Clin Chem Lab Med. 2002 Dec;40(12):1329-33. Review.

PMID:
12553439
16.
17.

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S; QUEST Study Group.

Clin Infect Dis. 2007 Aug 1;45(3):381-90. Epub 2007 Jun 26.

18.

The metabolic puzzle during the evolution of HIV infection.

Salas-Salvadó J, García-Lorda P.

Clin Nutr. 2001 Oct;20(5):379-91. Review.

PMID:
11534932
19.

Short-term energy restriction reduces resting energy expenditure in patients with HIV lipodystrophy and hypermetabolism.

Kosmiski LA, Bessesen DH, Stotz SA, Koeppe JR, Horton TJ.

Metabolism. 2007 Feb;56(2):289-95.

PMID:
17224345
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk